Moreover, using the same methodology, we determined that TCF2 was aberrantly methylated in 26 of 98 (26.5%) primary ovarian cancers, but not in any of the four samples of normal ovarian tissue analysed (Figure 1C). This evidence concerns the gene HNF1B and ovarian cancer.